HOME >> BIOLOGY >> NEWS
Association found between anthrax vaccination, medication and health problems of Gulf War veterans

clined a little bit. We did find that those who recalled that they did receive an anthrax vaccination during the Gulf War, their health deteriorated about twice as fast as folks in similar circumstances who didn't have a recollection of receiving that shot. "

Schumm said researchers also found that many of the medical records or shot records of the veterans had been falsified or destroyed, making it virtually impossible to use clinical data to assess the impact of vaccinations or the pyridostigmine bromide pills. In addition, many veterans reported taking incorrect dosages of the pyridostigmine bromide pills, most taking too few with some taking far too many. Only 24 percent of those reporting their average daily consumption of pills actually took the recommended three pills a day.

"Without actual medical records, it is very difficult to prove causality," Schumm said. "It would be pretty easy to discount any one study by itself as an anomaly since each of the studies have their own unique limitations, but obtaining the same results across different nationalities and research teams would seem to indicate that something went wrong with the process at that time for at least some of the veterans. Personally, I think the best guess is that the mix of pyridostigmine bromide pills, multiple vaccinations in a brief period of time, and high levels of stress combined to adversely affect the health of individuals with genetic susceptibility to such combinations."

Schumm noted that their research confirms results reported previously by British, Canadian, and other U.S. research teams with respect to vaccinations and pyridostigmine bromide consumption. He is working on a critique of a report recently released by the Institute of Medicine, clearing anthrax vaccine of any connection to health problems. Schumm said that it is possible that the anthrax vaccine as given today may be safe while the product as manufactured and administered during the Gulf War i
'"/>

Contact: Walter R. Schumm
wrschumm@k-state.edu
785-532-1494
Kansas State University
3-May-2002


Page: 1 2 3

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. National Corn Growers Association announces valuable maize genome data now available to scientists
3. Highlights of the July Journal of the American Dietetic Association
4. American Lung Associations 2004 State of the Air report ranks cities and counties with dirty air
5. Lunch workshop at the American Association for the Advancement of Science (AAAS) Annual Meeting
6. Highlights of the November 2003 Journal of the American Dietetic Association
7. Highlights of the October 2003 Journal of the American Dietetic Association
8. Mark your calendar for the American Anthropological Association meeting in Chicago Nov. 19-23
9. Applications accepted for research fellowships by the American Association for Cancer Research
10. Funding opportunities for junior faculty offered by the American Association for Cancer Research
11. Nominations sought for professorship by the American Association for Cancer Research

Post Your Comments:
(Date:4/13/2015)... CHICAGO , April 13, 2015  higi, a ... with ways to more fully engage with their communities ... its industry-leading, privacy protected and secure API.  ... API enables the most accessible, affordable, and convenient vehicle ... The API will ...
(Date:4/9/2015)... Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the third quarter of ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-438-5524 (conference ...
(Date:4/6/2015)... Conn. , Apr. 6, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/143028 for ... COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces a ... payments. This patent surrounds the use of miniature ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
(Date:4/17/2015)... Houston, TX (PRWEB) April 17, 2015 ... genomics and proteomics technologies, announced today that it ... sequencing system, an innovative multiplex PCR based targeted ... ultra-high resolution sequence analysis, that enables accurate detection ... pending Relay-PCR™ and Omega-Primer™ technologies. The company will ...
(Date:4/16/2015)... 16, 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) ... quarter results on Thursday, April 30, 2015 at 4:00 ... will host a conference call at 4:30 PM Eastern ... company’s outlook for the future. , The conference call ... the homepage and in the Investor Relations section of ...
(Date:4/16/2015)... According to the 2014 Liberty ... source was ranked first among the leading causes ... lifting, pushing, pulling, holding, carrying, or throwing and ... David Round Company takes statistics like this very ... to develop and design equipment that prevents these ...
(Date:4/16/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... venture with G-treeBNT (ReGenTree LLC) has retained Ora, ... for the orphan disorder, neurotrophic keratopathy (NK), and ... syndrome (DES) in the U.S.  Both trials will ... year.  Each of these eye disorders was being ...
Breaking Biology Technology:LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: